Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/126865
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | New oleyl glycoside as anti-cancer agent that targets on neutral sphingomyelinase |
Autor: | Romero-Ramírez, Lorenzo CSIC ORCID; García-Álvarez, Isabel; Casas, Josefina CSIC ORCID ; Barreda-Manso, M. Asunción CSIC ORCID; Yanguas-Casás, Natalia; Nieto-Sampedro, Manuel CSIC; Fernández-Mayoralas, Alfonso CSIC ORCID | Palabras clave: | Sphingomyelin ER stress Ceramide Glycosphingolipids Apoptosis |
Fecha de publicación: | 2015 | Editor: | Elsevier | Citación: | Biochemical Pharmacology 97: 158-172 (2015) | Resumen: | We designed and synthesized two anomeric oleyl glucosaminides as anti-cancer agents where the presence of a trifluoroacetyl group close to the anomeric center makes them resistant to hydrolysis by hexosaminidases. The oleyl glycosides share key structural features with synthetic and natural oleyl derivatives that have been reported to exhibit anti-cancer properties. While both glycosides showed antiproliferative activity on cancer cell lines, only the α-anomer caused endoplasmic reticulum (ER) stress and cell death on C6 glioma cells. Analysis of sphingolipids and glycosphingolipds in cells treated with the glycosides showed that the α-anomer caused a drastic accumulation of ceramide and glucosylceramide and reduction of lactosylceramide and GM3 ganglioside at concentrations above a threshold of 20 μM. In order to understand how ceramide levels increase in response to α-glycoside treatment, further investigations were done using specific inhibitors of sphingolipid metabolic pathways. The pretreatment with 3-O-methylsphingomyelin (a neutral sphingomyelinase inhibitor) restored sphingomyelin levels together with the lactosylceramide and GM3 ganglioside levels and prevented the ER stress and cell death caused by the α-glycoside. The results indicated that the activation of neutral sphingomyelinase is the main cause of the alterations in sphingolipids that eventually lead to cell death. The new oleyl glycoside targets a key enzyme in sphingolipid metabolism with potential applications in cancer therapy. | Versión del editor: | http://dx.doi.org/10.1016/j.bcp.2015.07.009 | URI: | http://hdl.handle.net/10261/126865 | DOI: | 10.1016/j.bcp.2015.07.009 | Identificadores: | doi: 10.1016/j.bcp.2015.07.009 issn: 0006-2952 e-issn: 1873-2968 |
Aparece en las colecciones: | (IQOG) Artículos (IQAC) Artículos (IC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
14
checked on 12-mar-2024
WEB OF SCIENCETM
Citations
13
checked on 25-feb-2024
Page view(s)
256
checked on 18-mar-2024
Download(s)
136
checked on 18-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.